Parallel Advisors’s Array Biopharma Inc ARRY Stock Holding History

Parallel Advisors’s Portfolio ARRY Stock Details ARRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-500	Closed	-$23K	–	2579
2019 Q2	$23K	Hold	500	–	–	﹤0.01%	1229
2019 Q1	$12K	Buy	500 +400	+400%	+$8.33K	﹤0.01%	1476
2018 Q4	$1K	Buy	+100	New	+$1.52K	﹤0.01%	2096
2017 Q2	–	Sell	-94	Closed	-$1K	–	2271
2017 Q1	$1K	Buy	+94	New	+$1K	﹤0.01%	1959

Other funds holding ARRY

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Parallel Advisors's ARRY Position: Q3 2019 in Review

Parallel Advisors sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 500 shares — an estimated $23K sold.

Parallel Advisors first reported a position in ARRY in Q1 2017 and held it in 4 quarters. The position peaked at $23K in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

Parallel Advisors reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
Parallel Advisors sold 500 Array Biopharma Inc shares in Q3 2019, an estimated $23K.
Parallel Advisors first reported a position in Array Biopharma Inc in Q1 2017 and held it in 4 quarters.
Parallel Advisors's Array Biopharma Inc position peaked at $23K in Q2 2019.
1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Parallel Advisors's 13F filing for Q3 2019, filed 1 Nov 2019.